Showing results (701-710 of 767) with videos related to
Sort By:
Pageof 77
The Lancet. Oncology|March 11, 2015
Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization GroupSaro H Armenian, Melissa M Hudson, Renee L Mulder, et al.Plos One|August 22, 2023
Effect of Test and Treat on clinical outcomes in Nigeria: A national retrospective studyMarie-Claude C Lavoie, Akipu Ehoche, Natalia Blanco, et al.Science Translational Medicine|August 2, 2013
mTORC1 inhibition is required for sensitivity to PI3K p110α inhibitors in PIK3CA-mutant breast cancerMoshe Elkabets, Sadhna Vora, Dejan Juric, et al.Cell Chemical Biology|August 22, 2018
Acyldepsipeptide Analogs Dysregulate Human Mitochondrial ClpP Protease Activity and Cause Apoptotic Cell DeathKeith S Wong, Mark F Mabanglo, Thiago V Seraphim, et al.Human Mutation|May 30, 2019
Predicting venous thromboembolism risk from exomes in the Critical Assessment of Genome Interpretation (CAGI) challengesGregory McInnes, Roxana Daneshjou, Panagiostis Katsonis, et al.BMJ Open|April 7, 2022
Concurrent chemoradiation and brachytherapy alone or in combination with nelfinavir in locally advanced cervical cancer (NELCER): study protocol for a phase III trialSupriya Chopra, Jayant Sastri Goda, Prachi Mittal, et al.JCO Precision Oncology|March 2, 2026
Molecular Profiling of Cholangiocarcinoma Predicts Outcomes Post-Liver TransplantationAshton A Connor, Mahinur Mattohti, Sudha Kodali, et al.Online Journal of Public Health Informatics|August 26, 2025
Use of Biometrics for Records Deduplication: Case Study of the National Data Repository in NigeriaAdemola Oladipo, Ibrahim Dalhatu, Stephen Taiye Balogun, et al.Journal of Clinical Medicine|August 27, 2021
Multidimensional Prognostic Index and Outcomes in Older Patients Undergoing Transcatheter Aortic Valve Implantation: Survival of the FittestJeannette A Goudzwaard, Sadhna Chotkan, Marjo J A G De Ronde-Tillmans, et al.Diabetes, Obesity & Metabolism|February 14, 2025
Fixed dose combination of dapagliflozin, glimepiride and extended-release metformin tablets in patients with type 2 diabetes poorly controlled by metformin and glimepiride: A phase III, open label, randomized clinical study in IndiaRakesh Sahay, Dinesh Gangwani, Manish Singh, et al.Pageof 77